AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $31,000 | -48.3% | 21,236 | -8.8% | 0.00% | – |
| Q4 2018 | $60,000 | -41.2% | 23,291 | 0.0% | 0.00% | – |
| Q3 2018 | $102,000 | -28.7% | 23,291 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $143,000 | -15.9% | 23,291 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $170,000 | -11.0% | 23,291 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $191,000 | -22.0% | 23,291 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $245,000 | +26.3% | 23,291 | +32.7% | 0.00% | 0.0% |
| Q2 2017 | $194,000 | – | 17,555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |